SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
FEMY reported Quarter ended September 30, 2026 results. The price and volatility reaction is pending.
FEMYearnings

Earnings reactions, page 2

Femasys Inc. (FEMY) FY2026 earnings

November 14, 2026 · SharpeIQ Research Desk

Reported results

  • U.S. sales were $347,039 for the quarter ended September 30, 2026, compared to $336,594 for the same period in 2025.
  • Overall sales were $404,597 for the quarter ended September 30, 2026, compared to $729,394 for the same period in 2025.
  • Research and development expenses were $1,942,927 for the quarter ended September 30, 2026, compared to $1,382,022 for the same period in 2025.
  • Net loss was $4,564,815, or ($0.53) per basic and diluted share, for the quarter ended September 30, 2026.
  • Cash and cash equivalents were approximately $23.9 million as of September 30, 2026.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →